about
A case of ST elevation myocardial infarction secondary to heparin-induced thrombocytopaenia with thrombosis.Prognosis and sleep disordered breathing in heart failure.Treatment of central sleep apnoea in congestive heart failure with nasal ventilationEhlers-Danlos syndrome during pregnancy: a case report and review of the literature.Possible atherogenic effects of hypoxia during obstructive sleep apnea.Aortic root dilatation in Marfan's syndrome: a contribution from obstructive sleep apnea?Pre-eclampsia is associated with marked alterations in sleep architecture.Diagnosis and treatment of obstructive sleep apnea is key to achieving optimal results after catheter ablation of atrial fibrillation.Hypoxia and inflammation.Electroencephalographic arousals during sleep do not alter the pressor response to Cheyne-Stokes respiration in subjects with chronic heart failure.Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep.Abnormal breathing during sleep and increased central chemoreflex sensitivity in congestive heart failure.Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea.The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusionComparison of exercise stress testing with ambulatory electrocardiographic monitoring in the detection of myocardial ischemia after unstable angina pectorisColour-coded imaging of cardiac blood flowColour Doppler echocardiographic assessment of regurgitant flow in mitral valve prolapseTreatment of snoring and obstructive sleep apnoea by rapid maxillary expansionHypercapnic blood pressure response is greater during the luteal phase of the menstrual cycleSnoring and sleep apnoea in men: association with central obesity and hypertensionDeterminants of prognosis in unstable anginaBasal stress cardiomyopathy induced by exogenous catecholamines in younger adults
P50
Q33401796-A5A946FF-10FD-4EE6-AB7F-E6491F874703Q33588210-8854BE11-57E2-49E2-9D63-B572E14A3EF0Q35577227-08AA39EB-4FCD-42A4-98B0-44B587306920Q40279474-1ED0EB2F-7879-44D1-9CCB-BFF2D93DD7A2Q40750043-C4BB1886-7C81-4062-91BB-0F49527D7810Q41501515-94B78543-301A-455A-868A-49F3037AA80BQ46354520-8653C97E-D8BC-4C07-9692-FCC6A5F84060Q48141949-A81DB3DE-D6BD-4A8D-8156-AB59AB4E3715Q48302451-634BAC85-D70D-4065-8DBE-62EDB9767EF9Q48450384-F05B95AC-75C7-4C1F-90E7-1466D5641CAAQ48686016-C8BD2959-7C7F-4EE7-A732-1D820E221CA7Q48714477-EBBAD3FB-52B0-4E47-B2F1-F43877DBC73CQ48863524-64C5632A-A906-4BC8-991D-3A5D030F182EQ67982569-F8A11BCA-E3D9-40D7-BCD6-A8E34DF9DDB8Q68180859-C10188D8-3675-42F3-BFBC-65FE5FDDE35DQ68278047-A2103625-FB5E-4B63-8113-9774528DD983Q69406056-55404CC7-F542-415F-87B9-E4BA3EECBF7BQ71541842-D0E9D61C-0312-4471-BCBE-B3ED0539B233Q71829509-0AFE4FF0-A4EB-4654-BA09-DCD23052BD85Q72557180-6381751C-4164-4429-88FF-D5D61BBC1A02Q72834133-99DA4954-609F-4B89-87A5-C8C3D8561F6FQ85769042-D28414A2-6EBA-4DEA-8C2C-4FC8D15AFC82
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6414-7453
@en
name
Ian Wilcox
@ast
Ian Wilcox
@en
Ian Wilcox
@es
Ian Wilcox
@nl
type
label
Ian Wilcox
@ast
Ian Wilcox
@en
Ian Wilcox
@es
Ian Wilcox
@nl
prefLabel
Ian Wilcox
@ast
Ian Wilcox
@en
Ian Wilcox
@es
Ian Wilcox
@nl
P106
P31
P496
0000-0002-6414-7453